Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
The planet's temperature spiked on Tuesday to its hottest day in at least 44 years and likely much longer, and Wednesday could become the third straight day Earth unofficially marks a record-breaking high, the latest in a series of climate-change extremes that alarm but don't surprise scientists.
